@article{417d50ce5dfb4f59b21ccebdd62a4e52,
title = "Prophylactic evaluation of verubecestat on disease- and symptom-modifying effects in 5XFAD mice",
keywords = "BACE inhibitor, MODEL-AD, amyloid, mouse model, preclinical testing",
author = "Oblak, {Adrian L.} and Cope, {Zackary A.} and Quinney, {Sara K.} and Pandey, {Ravi S.} and Carla Biesdorf and Masters, {Andi R.} and Onos, {Kristen D.} and Leslie Haynes and Keezer, {Kelly J.} and Meyer, {Jill A.} and Peters, {Jonathan S.} and Persohn, {Scott A.} and Bedwell, {Amanda A.} and Kierra Eldridge and Rachael Speedy and Gabriela Little and Williams, {Sean Paul} and Brenda Noarbe and Andre Obenaus and Michael Sasner and Howell, {Gareth R.} and Carter, {Gregory W.} and Harriet Williams and Lamb, {Bruce T.} and Territo, {Paul R.} and {Sukoff Rizzo}, {Stacey J.}",
note = "Publisher Copyright: {\textcopyright} 2022 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association.",
year = "2022",
doi = "10.1002/trc2.12317",
language = "English",
volume = "8",
journal = "Alzheimer's and Dementia: Translational Research and Clinical Interventions",
issn = "2352-8737",
number = "1",
}